The osteoprotegerin (OPG)/receptor activator of nuclear factor-κB ligand (RANKL)/receptor activator of NF-κB (RANK) system plays an important role in the pathogenesis of metabolic bone diseases. This study is aimed to investigate effects and mechanisms of RANKL gene silencing on the function of human osteoblast-like MG63 cells by RNA interference using a lentivirus-based small hairpin RNA (vshRNA) delivery system. After RANKL-specific vshRNAs were designed, constructed and transfected into MG63 cells, changes in the expression levels of RANKL mRNA and protein were determined by Western blot and RT-PCR, respectively; changes in cell activity and cell cycle distribution were examined by thiazolyl blue tetrazolium bromide assay and flow cytometry. The expression levels of RANKL mRNA and protein in MG63 cells were reduced by transferring RANKL-specific vshRNAs. Compared to cells infected with negative control virus, the proliferation of cells infected with the recombinant virus was more likely to be inhibited. Furthermore, the cell cycle of MG63 was altered, with the number of G1 phase cells decreasing significantly (P < 0.05). RANKL-specific vshRNAs can significantly inhibit the expression of the target gene in MG63 cells. RANKL gene silencing can inhibit the proliferation and alter the cell cycle of MG63 cells. Our findings suggest that RANKL might play an important role in the regulation of growth and cell cycle of MG63 cells.
Introduction
Numerous studies have shown that the OPG/RANKL/ RANK signaling system plays an important role in the pathogenesis of metabolic bone diseases (Hofbauer et al. 2004; Wada et al. 2006; Hamdy 2007) . Since OPG (osteoprotegerin) and RANK (receptor activator of nuclear factor-κB) exert their effects through binding competitively to RANKL (receptor activator of nuclear factor-κB ligand), RANKL plays a pivotal role in this signaling system (Mori et al. 2007; Sobacchi et al. 2007) .
RNA interference (RNAi), also known as posttranscriptional gene silencing (PTGS) (Fire et al. 1998; Maciej & Didier 2003) , can shut down almost any specific gene in a short time, and is therefore a suitable approach for the study of gene function, the screening of drug target genes and the validation of drug targets (Elbashir et al. 2001; Brummelkamp et al. 2002) .
MG63 cells, exhibiting characteristics of osteoblastic phenotype, are widely used in the study of metabolic bone diseases (Franceschi et al. 1985; Lincks et al. 1998; Pan et al. 1998 ). The present study is aimed to construct the recombinant lentiviral vector for the RANKL gene, transfect the constructed vector into MG63 cells to establish a model of cell infection. Through determining the expression levels of the target gene mRNA and protein, silencing of RANKL gene expression by lentivirus-mediated RNAi was evaluated. Besides effects of RANKL gene silencing on the function of MG63 cells was explored through dynamically observing changes in the cell activity and cell cycle distribution. The results obtained in this study lay a foundation Effects of receptor activator of NF-κB ligand gene 209 for searching a new target for gene therapy of metabolic bone diseases.
Material and methods

Materials
293T cells and MG63 cells (Shanghai Institute of Cell Biology, Chinese Academy of Sciences) were used as lentivirus packaging cells and target cells, respectively. RANKLspecific RNA interference using a lentivirus-based small hairpin RNAs (vshRNAs), designated as pGCL-GFP.retro-1, pGCL-GFP.retro-2 and pGCL GFP.retro-3, respectively, were synthesized by Shanghai GeneChem Co., Ltd. PCR primer design and double-stranded DNA (dsDNA) oligonucleotide synthesis were also performed by Shanghai GeneChem Co., Ltd. The other materials used included: extraction kit for large plasmid DNA (Qiagen, The Netherlands), restriction endonucleases (New England BioLabs, USA), positive cloning and sequencing (Invitrogen, USA), T4 DNA ligase (New England BioLabs, USA), lipofectamine 2000 (Invitrogen, USA), RANKL (c-20) monoclonal antibody (mAb), goat anti-rabbit IgG-horseradish peroxidase (HRP), goat anti-mouse IgG-HRP (Santa Cruz Biotechnology, USA), β-actin mAb (Abcam, England), reverse transcriptase (Promega, USA), DMEM (Dulbecco's minimum essential medium) (Gibco, USA), trypsin (Shanghai Chemical Reagent), protein electrophoresis system (Biorad, USA), PCR thermal cycler (Applied Biosystems, USA), real-time PCR thermal cycler (Biorad, USA), and microplate washer (model 1550, Biorad, USA).
Cell culture
Both 293T packaging cells and MG63 cells were cultured in high-glucose DMEM medium containing 10% fetal calf serum at 37
• C in the presence of 5% CO2. To passage cells, 0.25% trypsin was used to disperse cells.
Vector structure
The plasmid contained U6 promoter, which was used to obtain the continuing expression of the small RNA with an interference role in the host cell. Since this plasmid was able to express the cytomegalovirus promoter-driven green fluorescent protein (GFP), it was used to detect the transfection efficiency in virus packaging and host cells. After annealing, dsDNA formed, and linked to the pGCL-GFP vector through the digestion of Hpa I and Xho I, then transformed into E. coli DH5α. Picking the recombinant clone lines for PCR and sequencing (Shanghai BioAsia Biological Technology Co., Ltd.). Three pairs of recombinant pGCL-GFP plasmid vectors in RANKL target sequence were respectively named as pGCL-GFP1, pGCL-GFP2 and pGCL-GFP3. PCR primer identification of the positive clone: Up(+): 5'-GCCCCGGTTAATTTGCATAT-3'; Down(-): 5'-GTAATACGGTTATCCACGCG-3'.
RNAi lentivirus packaging
For encoding the lentiviral particles, preparation was made to get the recombinant virus plasmid (pGCL-GFP) and the two original vector plasmids for auxiliary packaging (pHelper 1.0 and 2.0). Three vectors received separate extraction of high purity without endotoxin. According to Invitrogen's lipofectamine 2000 instructions, co-transfection of 293T cells was completed. The full medium was prepared for use 8 hours later; the cell supernatant with rich lentiviral particles were collected 48 hours later, and high-titer lentiviral liquid was concentrated. Then the virus titer was calibrated and labelled in 293T cells. Lentivirus particles, produced by the transfection of the packaging cells from the PGCL-GFP1, pGCL-GFP2 and pGCL-GFP3 vectors, were named as pGCL-GFP.retro-1, pGCL-GFP.retro-2 and pGCL-GFP.retro-3, respectively.
Effects of vshRNAs on the expression of RANKL protein in MG63 cells (Western blot)
MG63 cells were cultivated in appropriate conditions to ensure good growth. Cells were seeded into 6-well culture plates one day prior to infection with the virus. Virus infection was performed by adding shRNA lentiviral particles at different MOIs (multiplicity of infection) into target cells. The GFP/red fluorescent protein (RFP) expression was observed under fluorescence microscopy three days after infection. Culture media were removed five days after infection, and pre-cooled lysis buffer (1×) was added to lyse cells for 10-15 min. An ultrasonic cell disrupter was used to disrupt cells (200W, 4 times, 5 seconds each time with an interval of 2 seconds). After the disrupted cells were centrifuged at 12,000 × g at 4
• C for 15 min, the supernatant was collected for protein concentration determination. The final protein concentration of each sample was adjusted to 2 µg/µL. After 6×loading buffer was added, each sample was boiled at 100
• C for 5-10 min. Equal amounts of protein were then resolved using SDS-PAGE. After electrophoresis, proteins were transferred to polyvinylidene difluoride membrane at a constant current of 400 mA at 4
• C for 120 min. The membrane was then blocked with 5% non-fat milk in Tris-buffered saline (TBS) plus 0.05% Tween 20 (TBST) either at room temperature for 1 hour or at 4
• C overnight. Monoclonal antibodies (mAbs) against the target protein or the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein were then incubated with the blocked membrane in 5% non-fat milk in TBST either at room temperature for 2 hours or at 4
• C overnight. The membrane was washed threetimes, 10 min for each, with TBST. After incubation with goat anti-rabbit IgG-HRP or goat anti-mouse IgG-HRP secondary antibodies in 5% non-fat milk in TBST at room temperature for 2 hours, the membrane was washed three-times again as described above. Subsequently, the membrane was washed once with TBS for 10 minutes. The Amersham Biosciences' enhanced chemiluminescence Western Blotting Detection Kit was used to detect the corresponding antigen. The exposure and development of the X-ray film (Kodak, USA) were conducted in a darkroom. 
Effect of vshRNAs on the expression of RANKL mRNA in MG63 cells (RT-PCR)
PGCL-GFP.retro-3 virus was used to infect MG63 cells.
RT-PCR was used to detect the expression of RANKL mRNA in MG63 cells to evaluate knockdown efficiency five days after infection. RT-PCR primer design: Premier 5 was used for primer design. The primers were RANKL upstream primer: 5'-CGCCAGCAGAGACTACAC-3'; RANKL downstream primer: 5'-ACGAACATGGAGCGGGAG-3'; hActin upstream primer: 5'-GTGGACATCCGCAAAGAC-3'; and hActin downstream primer: 5'-AAAGGGTGTAACGCAA-CTA-3'. Total RNA extraction: total RNA was prepared in accordance with the operating instructions provided by Trizol Reagents (Invitrogen, USA). Reverse transcription: reverse transcription was conducted in accordance with the operating instructions provided by the M-MLV reverse transcriptase (Promega, USA). RT-PCR detection: RT-PCR was performed using the Bio-rad iQ5. SYBR Master Mixture (Takara, USA). The PCR reaction system was comprised of: SYBR premix ex taq (10 µL), the upstream primer (1.0 µL), the downstream primer (1.0 µL), cDNA template (1.0 µL) and water (7.5 µL). The quantitative real-time PCR cycling parameters were 15 seconds of predenaturation at 95
• C followed by 40 cycles of 95
• C for 5 seconds and 60
• C for 30 seconds. The optical absorption values at each extension stage were read to plot the melting curve. Samples were denatured at 95
• C for 1 min and then cooled down to 55
• C to allow the full annealing of dsDNAs after PCR cycling, and PCR products were resolved on a gel to examine the specificity of PCR amplification.
Determination of cell growth by MTT assay Cells were divided into three groups: CON group (normal target cells), NC group (normal target cells infected with NC virus) and KD group (normal target cells infected with pGCL GFP.retro-3 virus). Each group set consisted of three repeated wells. Thiazolyl blue tetrazolium bromide (MTT) assay was carried out at four time points (one, two, three and four days after infection of target cells with pGCL GFP.retro-3, respectively). The OD values were used to evaluate cell proliferation and growth.
Determination of cell cycle by flow cytometry Each set of the three cell groups (CON group, NC group and KD group) consisted of three repeated wells. After infection with pGCL GFP.retro-3, target cells had been cultured for 10 days continuously. Propidium iodide (PI) staining was then performed using 4
• C pre-cooled ethanol to fix the cells, and the proportion of cells at different phases was calculated according to cellular fluorescence detected by flow cytometry (FCM).
Statistical analysis
All experimental data were analyzed by using the SPSS12.0. The measurements were expressed as mean ± standard deviation (x ±s), and the relevant figures were produced using the Microsoft Office Excel. Real-time PCR data were analyzed by 2 −∆∆Ct analysis method, and the relevant figures were drawn and analyzed using the GraphPad PRISM 4.0 software.
Results
Transfection of MG63 cells with virus
Three days after MG63 cells exhibited good growth, shRNA lentiviral particles were added at different MOIs. GFP/RFP expression was observed under fluorescence microscopy. The results showed that MG63 cells could only be infected by lentivirus at higher MOI values (MOI over 20) (Fig.1) . a Growth of MG63 cells (OD value) (n = 3). ANOVA analysis followed by the LSD test; ** the P-value is less than 0.01 when compared with the NC group; * the P-value is less than 0.05 when compared with the NC group. 
Effect of vshRNAs on the expression of RANKL protein in MG63 cells (Western blot)
The results showed that all the three vshRNAs designed could significantly knockdown the expression of RANKL protein in MG63 cells. Compared with the NC group, the expression of RANKL protein decreased significantly in the experimental group (Fig.2) . Effect of vshRNAs on the expression of RANKL mRNA in MG63 cells (RT-PCR) Table 1 and Figure 3 show that pGCL-GFP.retro-3 virus could significantly knockdown the expression of RANKL mRNA in MG63 cells, with a knockdown efficiency of more than 70%.
Effect of vshRNAs on the growth of MG63 cells by MTT assay Table 2 and Figure 4 illustrate that, compared with the NC group, the OD values in the KD group displayed a downward tendency one, two, three and four days af- ter infection. The significant difference in the OD value was observed between two and four days after infection (P < 0.05). The results indicated that the knockdown of RANKL gene has an inhibitory effect on the growth of MG63 cells.
Effect of vshRNAs on the cell cycle of MG63 cells by FCM
Compared with the NC group, the KD group displayed a decrease in the number of cells in G1 phase (P < 0.05), an increase tendency in G2 phase, and no change in S phase, which indicated that the knockdown of RANKL gene could result in the change in percent of cells in G1; the cell cycle changes were not statistically significant (Table 3 and Figs 5-6).
Discussion
Lentiviral vectors comprising a basic retroviral structure belong to a third-generation RNA interference vector system (Abbas et al. 2002; Moffat et al. 2006 was used for RNA interference experiments in this study. Since specific siRNA design largely depends on previous experience and three to four sequences are usually designed for each gene, we designed three sequences in the present study. Our results showed that RANKL gene expression was inhibited in MG63 cells, which indicated that lentiviral vector expressing human RANKL-specific shRNAs was successfully constructed. Great attention has been paid to the search for sensitive biological markers in the prevention and treatment of metabolic bone diseases. Some studies have shown that the OPG/RANKL/RANK signal transduction pathway is closely related to the pathogenesis of many metabolic bone diseases. The RANKL gene is ex-pressed in osteoblasts and marrow stroma cells. Once being bound to the RANK on the surface of osteoclast precursor cells or osteoclasts, the RANKL can promote osteoclast differentiation and display bone resorption activity. In contrast, the OPG protein is expressed and secreted by osteoblast precursor cells and bone marrow stroma cells. Through competitive binding to the RANKL, the OPG protein can block the interaction between RANK and RANKL, and therefore inhibit osteoclast differentiation (Simonet et al. 1997; Yasuda et al. 1998; Tanaka 2007) . Thus, OPG and RANKL exert their effects through competitive binding to RANKL. Considering that RANKL plays a pivotal role in the OPG/RANKL/RANK axis, silencing this gene may have an important effect on the biological behaviour of MG63 cells.
In order to explore the mechanisms underlying the effect of RANKL gene silencing on the function of MG63 cells, a recombinant lentiviral expression vector system was established in this study. After being transfected with RANKL-specific vshRNAs, the growth and cell cycle of MG63 cells were detected by MTT assay and FCM, respectively. Our results indicated that RANKL gene silencing could inhibit the growth of MG63 cells and alter their cell cycle progression. And the number of G1 phase cells decreased significantly, while that of G2 phase cells displayed an upward tendency.
In summary, RANKL-specific vshRNAs can significantly inhibit the expression of RANKL gene in MG63 cells. Our findings suggest that RANKL might play an important role in the regulation of growth and cell cycle of MG63 cells.
